APA (7th ed.) Citation

G, L., H, T., M, Z., B, A., C, H., F, F., . . . N, S. (2024). Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: A retrospective comparison of two randomized phase 3 trials. Leukemia, 38(12), 2709. https://doi.org/10.1038/s41375-024-02420-6

Chicago Style (17th ed.) Citation

G, Lenz, et al. "Pola-R-CHP or R-CHOEP for First-line Therapy of Younger Patients with High-risk Diffuse Large B-cell Lymphoma: A Retrospective Comparison of Two Randomized Phase 3 Trials." Leukemia 38, no. 12 (2024): 2709. https://doi.org/10.1038/s41375-024-02420-6.

MLA (9th ed.) Citation

G, Lenz, et al. "Pola-R-CHP or R-CHOEP for First-line Therapy of Younger Patients with High-risk Diffuse Large B-cell Lymphoma: A Retrospective Comparison of Two Randomized Phase 3 Trials." Leukemia, vol. 38, no. 12, 2024, p. 2709, https://doi.org/10.1038/s41375-024-02420-6.